Quest Diagnostics Q4 2024 Earnings Report Highlights Growth and Strategic Acquisitions
Quest Diagnostics (DGX) reported 15% revenue growth in Q4 2024, with 5% organic growth, and 7% full-year revenue growth. The company completed eight acquisitions, including LifeLabs in Canada, and expanded its diagnostic services. The earnings call highlighted improvements in profitability, automation, and employee retention.
Tickers: $DGX
Topics: acquisitions earnings call financial guidance profitability revenue growth